APA Alıntı

Zeymer, U., Lober, C., Wolf, A., Richard, F., Schäfer, H., Taggeselle, J., . . . Süselbeck, T. (2020). Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry. Cardiol Ther.

Chicago Stili Alıntı

Zeymer, Uwe, Christiane Lober, Andreas Wolf, Frank Richard, Heinrich Schäfer, Jens Taggeselle, Hans-Joachim Kabitz, Roland Prondzinsky, ve Tim Süselbeck. "Use, Persistence, Efficacy, and Safety of Apixaban in Patients With Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry." Cardiol Ther 2020.

MLA Alıntı

Zeymer, Uwe, et al. "Use, Persistence, Efficacy, and Safety of Apixaban in Patients With Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry." Cardiol Ther 2020.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..